Preliminary data-collections indicate there may be a specific type of opioid receptor related to opioid's ability to reinforce its own intake. The possibility of a specific receptor became apparent by studying diprenorphine, a mixed agonist-antagonist which antagonizes many events of morphine but which shows signs of having capability to elicit opioid-positive-affect. The research to be done will follow the preliminary findings and explore the dimensions of diprenorphine's effects as well as studying diprenorphine's site to action. Among people, TRC, the active ingredient of marijuana, clearly produces signs of positive affect. Yet, we have little or no capability of studying THC-elicited positive affect in laboratory subjects, such as rats. Consequently, we have little information concerning how THC may induce positive affect which is one the features by which THC sustains its own intake. Research will be done leading to the capability of measuring THC-elicited positive affect among rats and, thereby, begin the process of studying how THC achieves its positively reinforcing effects. It is clearly a possibility that opioids and THC's rewarding effects are mediated by way of similar processes. Research is proposed which will delineate which neurochemical systems are critical to both opioid and THC's rewarding features.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
1R01DA004440-01A2
Application #
3210095
Study Section
Pharmacology I Research Subcommittee (DABR)
Project Start
1988-08-01
Project End
1991-07-31
Budget Start
1988-08-01
Budget End
1989-07-31
Support Year
1
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Rensselaer Polytechnic Institute
Department
Type
Schools of Arts and Sciences
DUNS #
002430742
City
Troy
State
NY
Country
United States
Zip Code
12180
Bilsky, E J; Montegut, M J; Nichols, M L et al. (1998) CGS 10746B, a novel dopamine release inhibitor, blocks the establishment of cocaine and MDMA conditioned place preferences. Pharmacol Biochem Behav 59:215-20
Reid, L D (1996) Endogenous opioids and alcohol dependence: opioid alkaloids and the propensity to drink alcoholic beverages. Alcohol 13:5-11
Reid, L D; Hubbell, C L; Glaccum, M B et al. (1993) Naltrindole, an opioid delta receptor antagonist, blocks cocaine-induced facilitation of responding for rewarding brain stimulation. Life Sci 52:PL67-71
Hubbell, C L; Chrisbacher, G A; Bilsky, E J et al. (1992) Manipulations of the renin-angiotensin system and intake of a sweetened alcoholic beverage among rats. Alcohol 9:53-61
Bilsky, E J; Montegut, M J; Delong, C L et al. (1992) Opioidergic modulation of cocaine conditioned place preferences. Life Sci 50:PL85-90
Reid, L D; Delconte, J D; Nichols, M L et al. (1991) Tests of opioid deficiency hypotheses of alcoholism. Alcohol 8:247-57
Nichols, M L; Hubbell, C L; Kalsher, M J et al. (1991) Morphine increases intake of beer among rats. Alcohol 8:237-40
Bilsky, E J; Hubbell, C L; Delconte, J D et al. (1991) MDMA produces a conditioned place preference and elicits ejaculation in male rats: a modulatory role for the endogenous opioids. Pharmacol Biochem Behav 40:443-7
Bilsky, E J; Reid, L D (1991) MDL72222, a serotonin 5-HT3 receptor antagonist, blocks MDMA's ability to establish a conditioned place preference. Pharmacol Biochem Behav 39:509-12
Hubbell, C L; Marglin, S H; Spitalnic, S J et al. (1991) Opioidergic, serotonergic, and dopaminergic manipulations and rats' intake of a sweetened alcoholic beverage. Alcohol 8:355-67

Showing the most recent 10 out of 14 publications